Skip to search formSkip to main contentSkip to account menu

Percent Free Prostate-Specific Antigen Measurement

Known as: Free Prostate-Specific Antigen, Percent Free Prostate-Specific Antigen, free PSA 
The amount of the protein prostate-specific antigen (PSA) in the blood that is not attached to other proteins. It is compared with the amount of PSA… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The use of serum [‐2]proPSA (p2PSA) and its derivative, the prostate health index (PHI), in detecting prostate cancer (PCa) have… 
Highly Cited
2009
Highly Cited
2009
The aim of this study was to combine the new automated Access [‐2]proPSA (p2PSA) assay with a percent free PSA (%fPSA) based… 
2008
Highly Cited
2007
Highly Cited
2007
Clinicians currently use simple cut‐points, such as serum prostate‐specific antigen (PSA) ≥≥4 ng/ml, to decide whether to… 
2004
2004
Recent studies have reported enhanced prostate cancer detection in Caucasians with serum human glandular kallikrein 2 (hK2) in… 
2004
2004
BACKGROUND The combined use of free and total prostate-specific antigen (PSA) in early detection of prostate cancer has been… 
2001
2001
Introduction: The aim of our study was to evaluate the clinical usefulness of percent free prostate-specific antigen (PSA) [ratio… 
Highly Cited
1997
Highly Cited
1997
The ratio of free prostate‐specific antigen (f‐PSA) to total PSA (t‐PSA) in serum, calculated as percent free PSA (f‐PSA%), is…